Top Core and Group Health Stories
Eli Lilly's $35 insulin cap could unravel, as $13.5M class action settlement falls apart
By Amanda BronstadEli Lilly had agreed to cap the price of insulin at $35 per month for 4 years and provide a $13.5 million cash fund, however, a dozen state attorneys general, some with their own insulin lawsuits, had objected to the settlement.










